Literature DB >> 12006811

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity.

Konstantin Zedtwitz-Liebenstein1, Christoph Wenisch, Sandra Patruta, Berhard Parschalk, Florian Daxböck, Wolfgang Graninger.   

Abstract

OBJECTIVE: Neutrophils play a crucial role in host defense against infectious disease. The objective was to analyze the effect of omeprazole treatment on indexes of neutrophil function in healthy subjects.
DESIGN: Open.
SETTING: University hospital.
SUBJECTS: Ten healthy subjects. INTERVENTION: Analysis of blood samples before and after omeprazole administration.
MEASUREMENTS AND MAIN RESULTS: Neutrophil Escherichia coli phagocytosis was assessed by microscopy and flow cytometry. Intracellular production of reactive oxygen intermediates was measured by flow cytometry. Extracellular reactive oxygen intermediate production was assessed with a cytochrome c reduction assay. Neutrophil bactericidal capacity and intracellular concentrations of Ca2+ were determined by fluorometry. Four hours after a single 40-mg dose of omeprazole, intra- and extracellular reactive oxygen intermediate production by neutrophils was significantly reduced compared with pretreatment values: -30% (24% to 42%) (median and range) and -22% (21% to 68%; p <.05 for both). The intracellular Ca2+ concentrations in resting neutrophils were significantly increased (+33%, 21% to 39%, compared with pretreatment concentrations, p <.001) and neutrophilic bactericidal activity was decreased (-30%, 19% to 47%, compared with pretreatment concentrations, p <.0001). Intracellular Ca2+ concentrations correlated with intracellular reactive oxygen intermediate production and neutrophilic bactericidal capacity (r =.730 and r =.618, p <.05 for both, respectively). In contrast, phagocytosis rates were not impaired by omeprazole.
CONCLUSIONS: Our results imply that omeprazole impairs production of reactive oxygen intermediates by neutrophils. Whether specific impairments of neutrophil host defenses occur in vivo remains uncertain. Reduced bactericidal activity is associated with an increase of intracellular Ca2+ concentrations in resting neutrophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006811     DOI: 10.1097/00003246-200205000-00026

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  58 in total

1.  Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

Authors:  Janet T Holbrook; Robert A Wise; Benjamin D Gold; Kathryn Blake; Ellen D Brown; Mario Castro; Allen J Dozor; John J Lima; John G Mastronarde; Marianna M Sockrider; W Gerald Teague
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

2.  Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.

Authors:  Jason E Lang; Janet T Holbrook; Edward B Mougey; Christine Y Wei; Robert A Wise; W Gerald Teague; John J Lima
Journal:  Ann Am Thorac Soc       Date:  2015-06

3.  Correlation between proton pump inhibitors and risk of pyogenic liver abscess.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-04-22       Impact factor: 2.953

Review 4.  Stress-related mucosal disease in the critically ill patient.

Authors:  Marc Bardou; Jean-Pierre Quenot; Alan Barkun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-06       Impact factor: 46.802

5.  Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Authors:  Sascha Dublin; Rod L Walker; Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Lisa A Jackson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

6.  Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?

Authors:  Alexander L Fohl; Randolph E Regal
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-06-06

7.  Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.

Authors:  Hau-Hsin Wu; Yung-Tai Chen; Chia-Jen Shih; Yi-Tzu Lee; Shu-Chen Kuo; Te-Li Chen
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

8.  Intravenous pantoprazole utilization in a level 1 trauma center.

Authors:  David A Edelman; Krupa R Patel; James G Tyburski; Lisa G Hall Zimmerman
Journal:  Surg Endosc       Date:  2007-08-21       Impact factor: 4.584

9.  Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.

Authors:  Hiroshi Ichikawa; Norimasa Yoshida; Tomohisa Takagi; Naoya Tomatsuri; Kazuhiro Katada; Yutaka Isozaki; Kazuhiko Uchiyama; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 10.  Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Authors:  Ramalinga R Kedika; Rhonda F Souza; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.